The nocebo effect and patient perceptions of biosimilars in inflammatory bowel disease

被引：6
|
作者：
Pineles, David [1 ]
Malter, Lisa [2 ]
Liang, Peter S. [3 ]
Arsuaga, Amy [4 ]
Bosworth, Brian [1 ,4 ]
Hudesman, David P. [4 ]
Chang, Shannon [4 ]
机构：
[1] NYU Langone Hlth, Dept Med, New York, NY USA
[2] Bellevue Hosp, Div Gastroenterol, New York, NY USA
[3] Manhattan Med Ctr, VA New York Harbor Healthcare Syst, Div Gastroenterol, New York, NY USA
[4] NYU Langone Hlth, Div Gastroenterol, Inflammatory Bowel Dis Ctr, New York, NY 10016 USA
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2018年 / 74卷 / 10期
关键词：
D O I：
10.1007/s00228-018-2492-7
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1361 / 1362
页数：2
相关论文
共 50 条
  • [1] The nocebo effect and patient perceptions of biosimilars in inflammatory bowel disease
    David Pineles
    Lisa Malter
    Peter S. Liang
    Amy Arsuaga
    Brian Bosworth
    David P. Hudesman
    Shannon Chang
    European Journal of Clinical Pharmacology, 2018, 74 : 1361 - 1362
  • [2] Patient Perceptions Regarding the Use of Biosimilars in Inflammatory Bowel Disease
    Pineles, David
    Arsuaga, Amy
    Malter, Lisa B.
    Bosworth, Brian P.
    Hudesman, David P.
    Chang, Shannon
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S418 - S419
  • [3] Biosimilars in Inflammatory Bowel Disease
    Buchner, Anna M.
    Schneider, Yecheskel
    Lichtenstein, Gary R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (01) : 45 - 56
  • [4] Biosimilars in inflammatory bowel disease
    Siegmund, B.
    Atreya, R.
    Bokemeyer, B.
    Kruis, W.
    Mudter, J.
    Sander, C.
    Schreiber, S.
    Reindl, W.
    Zeissig, S.
    Kucharzik, T.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (11): : 1217 - 1222
  • [5] Biosimilars in inflammatory bowel disease
    Moore, Gregory T.
    MEDICAL JOURNAL OF AUSTRALIA, 2016, 205 (07) : 294 - 295
  • [6] Biosimilars in inflammatory bowel disease
    Gargallo, Carla J.
    Lue, Alberto
    Gomollon, Fernando
    MINERVA MEDICA, 2017, 108 (03) : 239 - 254
  • [7] Biosimilars in inflammatory bowel disease
    Talathi, Saurabh
    Baig, Kondal R. Kyanam Kabir
    JOURNAL OF DIGESTIVE DISEASES, 2020, 21 (11) : 610 - 620
  • [8] Nocebo effect and biosimilars in inflammatory bowel diseases: what's new and what's next?
    D'Amico, Ferdinando
    Solitano, Virginia
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (01) : 47 - 55
  • [9] Biosimilars in Inflammatory Bowel Disease (IBD): Experiences and perceptions of german gastroenterologists
    Bokemeyer, Bernd
    Dignass, Axel
    Schreiber, Stefan
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (04): : 369 - 374
  • [10] Biosimilars and the nocebo effect
    Braun, J.
    Tsiami, S.
    Buehring, B.
    Kiefer, D.
    Andreica, I
    Baraliakos, X.
    Kiltz, U.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 267 - 275
12345